c-Met (Cytoplasmic) Rekombinanter Antikörper

c-Met (Cytoplasmic) Rekombinant Antikörper für WB, FC (Intra), ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus, Ratte

Anwendung

WB, FC (Intra), ELISA

Konjugation

Unkonjugiert

CloneNo.

2G12

Kat-Nr. : 82904-1-RR

Synonyme

c-Met, MET, HGF receptor, EC:2.7.10.1, c Met



Geprüfte Anwendungen

Erfolgreiche Detektion in WBHepG2-Zellen, HEK-293-Zellen, Mauslebergewebe, Rattenlebergewebe
Erfolgreiche Detektion in FC (Intra)HeLa-Zellen

Empfohlene Verdünnung

AnwendungVerdünnung
Western Blot (WB)WB : 1:2000-1:10000
Durchflusszytometrie (FC) (INTRA)FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Produktinformation

82904-1-RR bindet in WB, FC (Intra), ELISA c-Met (Cytoplasmic) und zeigt Reaktivität mit human, Maus, Ratten

Getestete Reaktivität human, Maus, Ratte
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen c-Met (Cytoplasmic) fusion protein Ag23140
Vollständiger Name met proto-oncogene (hepatocyte growth factor receptor)
Berechnetes Molekulargewicht 1390 aa, 155 kDa
Beobachtetes Molekulargewicht140 kDa
GenBank-ZugangsnummerBC130420
Gene symbol MET
Gene ID (NCBI) 4233
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS with 0.02% sodium azide and 50% glycerol
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

c-Met (also named MET or HGFR) is a receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to the HGF ligand. c-Met regulates many physiological processes including proliferation, scattering, morphogenesis, and survival. The primary single-chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide-linked to form the mature receptor. Overexpression and/or mutation of c-Met has been reported in various human malignancies, including lung cancer, breast cancer, head and neck cancer, gastric cancer, colorectal cancer, bladder cancer, uterine cervix carcinoma, esophageal carcinoma, c-Met could serve as an important therapeutic target (PMID: 26036285). The c-met receptor is a 190-kD glycoprotein consisting of a 145-kD membrane-spanning beta chain and a 50-kD alpha chain (PMID: 7806559). In Western blot, this antibody produces bands of unknown identity at 55 and 100 kDa.

Protokolle

PRODUKTSPEZIFISCHE PROTOKOLLE
WB protocol for c-Met (Cytoplasmic) antibody 82904-1-RRProtokoll herunterladen
FC protocol for c-Met (Cytoplasmic) antibody 82904-1-RRDownload protocol
STANDARD-PROTOKOLLE
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen